Skip to main content

Table 1 Characteristics of the study population, and compliance with daily application of study cream

From: A phase i study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates

Male infant

6/10

Number of parents with allergic disease

 

1 parent

9/10

2 parents

1/10

Age in weeks at:

Median (IQR)*

commencement of treatment

2.1 (1.3-2.9)

follow-up

9.5 (7.6-10.1)

Application of study cream - medians (range)

 

days cream applied (max = 42)

38.5 days (35-42)

proportion of eligible days applied

92% (83%-100%)

total quantity applied

158 g (150-207)

average quantity applied per day

3.8 g (3.6-4.9)

average quantity applied per day on days used

4.4 g (3.8-4.9)

  1. *IQR interquartile range.